Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Figure 1 from KRAS Loss of Heterozygosity Promotes MAPK-Dependent Pancreatic Ductal Adenocarcinoma Initiation and Induces Therapeutic Sensitivity to MEK Inhibition
  1. Home
  2. Publications
  3. Supplementary Figure 1 from KRAS Loss of Heterozygosity Promotes MAPK-Dependent Pancreatic Ductal Adenocarcinoma Initiation and Induces Therapeutic Sensitivity to MEK Inhibition

Supplementary Figure 1 from KRAS Loss of Heterozygosity Promotes MAPK-Dependent Pancreatic Ductal Adenocarcinoma Initiation and Induces Therapeutic Sensitivity to MEK Inhibition

Authors:
  • SFSigrid K. Fey
    Sigrid K. Fey
  • ANArafath K. Najumudeen
    Arafath K. Najumudeen
  • DWDale M. Watt
    Dale M. Watt
  • LMLaura M. Millett
    Laura M. Millett
  • CFCatriona A. Ford
    Catriona A. Ford
  • KGKathryn Gilroy
    Kathryn Gilroy
  • RSRosalin J. Simpson
    Rosalin J. Simpson
  • KMKathy McLay
    Kathy McLay
  • RURosanna Upstill-Goddard
    Rosanna Upstill-Goddard
  • DCDavid Chang
    David Chang
  • WCWilliam Clark
    William Clark
  • CNColin Nixon
    Colin Nixon

Open Access
Publisher website
Google Scholar
  • 17 June 2026
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/0008-5472.32696882
Abstract
Increased fibrosis in wild-type Kras deficient PanINs.
Keywords
  • CELL SIGNALING
  • DRUG TARGETS
  • PROTEIN KINASE & PHOSPHATASE DRUG TARGETS
  • GASTROINTESTINAL CANCERS
  • PANCREATIC CANCER
  • ONCOGENES & TUMOR SUPPRESSORS
  • KRAS
  • PROGRESSION, INVASION & METASTASIS
  • TUMOR PROGRESSION
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.